At EU Parliament in Brussels, 620 MEPs vote in favor of the “diplomatic drive” for a global ban on cosmetic animal testing by 2023, with 14 voting against the measure and 18 abstaining. Europe fully banned cosmetic animal testing five years ago, but it is not banned in 80% of the world and convincing other governments to adopt a ban is a challenge given the lack of accepted non-animal alternatives for certain safety endpoints.
A large majority of members of European Parliament support a worldwide ban on animal testing of cosmetics and cosmetic ingredients in a resolution that is non-binding but could have far-reaching implications.
During a May 2-3 plenary session of Parliament in Brussels, 620 MEPs voted in favor of the “diplomatic drive” for...
Green Pharmaceuticals’ SnoreStop Nasal Spray, previously marketed as “NasoSpray,” still is available even though agency officials on multiple occasions for a month recommended a recall after an April inspection found “gross microbial contamination” in one lot.
Week after publishing safety alert about OPMS Black Liquid Kratom “linked to serious adverse health effects, including death,” FDA announced market research “to understand and characterize emergent risk/safety and perceived benefits reportedly linked to kratom and psychedelics.” But it withdrew the study 10 days later.
Semi-annual regulatory agenda of non-binding target dates also sets December goal for an NPRM to recognize N-acetyl-L-cysteine as a lawful dietary ingredient. Like IND exemptions rule, item on NAC included for first time in FDA’s list.
This HBW Insight series profiles regulatory affairs specialists working in or supporting the consumer health and beauty product industries. In this installment, we speak to Kenvue's Kevin Whelan.
Court order dismisses claims against Perrigo and Joseph Papa, its former CEO, with prejudice. Settlement also bars any claim against plaintiffs and class members, “whether arising under state, federal, common or foreign law,” alleging liability for losses.
In this episode of the Over the Counter podcast, HBW Insight speaks to Kerry's RDA senior manager of immune and joint health, Sonja Nodland, about the opportunity for innovation that postbiotics represent for the consumer health industry.
Proposal to have panelists rate the strength of efficacy and safety evidence on a numeric scale also draws support in written comments on ways to optimize the advisory committee process.
